Enovis Return on Tangible Equity 2010-2023 | ENOV
Enovis Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2023-12-31 | $-0.03B | $0.23B | -10.75% |
2023-09-30 | $-0.08B | $0.31B | -22.21% |
2023-06-30 | $-0.14B | $0.31B | -40.61% |
2023-03-31 | $-0.05B | $0.38B | -13.73% |
2022-12-31 | $-0.01B | $0.36B | -7.94% |
2022-09-30 | $0.02B | $0.33B | 4.78% |
2022-06-30 | $0.12B | $0.45B | 46.54% |
2022-03-31 | $0.07B | $-0.43B | -151.11% |
2021-12-31 | $0.07B | $1.57B | -65.60% |
2021-09-30 | $0.11B | $-0.59B | -12.58% |
2021-06-30 | $0.09B | $-0.73B | -8.89% |
2021-03-31 | $0.06B | $-0.69B | -4.59% |
2020-12-31 | $0.04B | $-1.39B | -2.91% |
2020-09-30 | $-0.01B | $-1.42B | 0.55% |
2020-06-30 | $-0.01B | $-1.47B | 0.70% |
2020-03-31 | $-0.47B | $-1.50B | 28.06% |
2019-12-31 | $-0.53B | $-1.43B | 25.73% |
2019-09-30 | $-0.47B | $-1.91B | 34.29% |
2019-06-30 | $-0.44B | $-1.88B | 50.77% |
2019-03-31 | $0.06B | $-2.98B | -16.30% |
2018-12-31 | $0.14B | $1.35B | 33.96% |
2018-09-30 | $0.11B | $0.01B | 91.06% |
2018-06-30 | $0.12B | $0.07B | 96.06% |
2018-03-31 | $0.14B | $0.21B | 318.60% |
2017-12-31 | $0.15B | $0.17B | -173.56% |
2017-09-30 | $0.18B | $0.05B | -101.44% |
2017-06-30 | $0.16B | $-0.26B | -55.00% |
2017-03-31 | $0.15B | $-0.31B | -42.90% |
2016-12-31 | $0.13B | $-0.17B | -32.93% |
2016-09-30 | $0.14B | $-0.40B | -27.69% |
2016-06-30 | $0.13B | $-0.47B | -23.56% |
2016-03-31 | $0.14B | $-0.52B | -26.67% |
2015-12-31 | $0.17B | $-0.56B | -32.67% |
2015-09-30 | $0.20B | $-0.58B | -39.57% |
2015-06-30 | $0.26B | $-0.42B | -51.78% |
2015-03-31 | $0.40B | $-0.50B | -73.65% |
2014-12-31 | $0.37B | $-0.56B | -100.82% |
2014-09-30 | $0.33B | $-0.52B | -92.53% |
2014-06-30 | $0.30B | $-0.58B | -105.78% |
2014-03-31 | $0.16B | $0.19B | -76.17% |
2013-12-31 | $0.16B | $-0.50B | -36.94% |
2013-09-30 | $0.14B | $-0.25B | -28.57% |
2013-06-30 | $0.09B | $-0.29B | -16.94% |
2013-03-31 | $0.05B | $-0.66B | -7.78% |
2012-12-31 | $-0.08B | $-0.72B | 15.66% |
2012-09-30 | $-0.11B | $-0.50B | 31.34% |
2012-06-30 | $-0.11B | $-0.48B | 48.93% |
2012-03-31 | $-0.11B | $-0.42B | 105.97% |
2011-12-31 | $0.01B | $-0.06B | 166.67% |
2011-09-30 | $0.03B | $0.03B | 141.18% |
2011-06-30 | $0.03B | $0.03B | 160.00% |
2011-03-31 | $0.02B | $0.01B | 143.28% |
2010-12-31 | $0.02B | $0.02B | 93.15% |
2010-09-30 | $0.02B | $0.02B | 61.22% |
2010-06-30 | $0.02B | $0.02B | 65.93% |
2010-03-31 | $0.02B | $0.02B | 83.95% |
2009-12-31 | $0.02B | $0.04B | 168.42% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.779B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
Axonics (AXNX) | United States | $3.435B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
10x Genomics (TXG) | United States | $3.022B | 0.00 |
Azenta (AZTA) | United States | $3.015B | 163.85 |
Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
Privia Health (PRVA) | United States | $2.238B | 99.26 |
Schrodinger (SDGR) | United States | $1.679B | 0.00 |
Omnicell (OMCL) | United States | $1.376B | 47.56 |
Phreesia (PHR) | United States | $1.237B | 0.00 |
Standard BioTools (LAB) | United States | $0.650B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
Talkspace (TALK) | United States | $0.451B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.342B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
Outset Medical (OM) | United States | $0.214B | 0.00 |
Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
American Well (AMWL) | United States | $0.150B | 0.00 |
Augmedix (AUGX) | United States | $0.128B | 0.00 |
TruBridge (TBRG) | United States | $0.121B | 5.17 |
MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
111 (YI) | China | $0.094B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Zepp Health (ZEPP) | China | $0.051B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
Movano (MOVE) | United States | $0.039B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Syra Health (SYRA) | United States | $0.012B | 0.00 |
Biotricity (BTCY) | United States | $0.011B | 0.00 |
ETAO (ETAO) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |